Response to Faricimab in refractory Caucasian Polypoidal Choroidal Vasculopathy (PCV) switchers
Switching to faricimab resulted in anatomical and functional stability in the majority of previously treated PCV patients and was well tolerated during the study period.
Authors
- Bhagyashree Joshi (ORCID: https://orcid.org/0000-0001-8787-5085)
- Gabriella De Salvo (ORCID: https://orcid.org/0000-0002-1185-6942)
- Mohamed Oshallah (ORCID: https://orcid.org/0000-0002-6290-0368)
- Grace Kiew
- Anastasios Sepetis (ORCID: https://orcid.org/0000-0002-9034-635X)
- Giulia Caruso (ORCID: https://orcid.org/0000-0003-4349-2941)
- Bhavan Bhachech
Institutions
- University of Southampton (GB)
Publication Details
- Journal
- Retina
- Published
- 2026-03-16
- DOI
- https://doi.org/10.1097/iae.0000000000004834
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00